The main focus in proteomic studies is on the identification of proteins in given biological samples. Proteins isolated and separated from a given sample (e.g., whole cell lysates, blood or tissue, protein complexes) by immunoprecipitation or affinit more
Genotypes in Smokers: Correlations with Smoking BehaviorPeter Bauer1*, Susan Collins2, and Anil Batra2
1Department of Medical Genetics, University of Tübingen, Germany; 2Clinic for Psychiatry and Psychotherapy, University of Tübingen, Germany
Smoking behavior is influenced by both genetic and environmental factors. Moreover, smoking initiation and smoking persistence have a heritability of at least 50%. A large body of work has been dedicated to associating multiple genetic markers of neurobiological pathways previously linked to addiction and smoking such as the central dopaminergic, serotoninergic, and nicotinergic pathways with different aspects of smoking behavior. In order to investigate the feasability of future genetic analyses, we genotyped 14 SNPs in 288 samples of addicted smokers using the LightCycler® 480 System with HybProbe assays.
Materials and Methods
Blood samples were taken from 272 volunteers who had given informed consent for analysis of target genes presumably involved in nicotine addiction. DNA was prepared using either a manual high-salt method (236 samples) or the MagNA Pure Compact Instrument with the Nucleic Acid Isolation Kit I (36 samples).
PCR primers and HybProbe probes for the analysis of 14 different SNPs (Figure 1) were designed by Tib Molbiol (Berlin). A BioRobot 8000 platform was programmed to perform PCR setups using the LightCycler® 480 Genotyping Master in 384-well microtiter plates. Details of the PCR reaction are given elsewhere . In brief, we used 10 pmol of each primer and 3 pmol of each HybProbe probe (anchor and sensor). PCR volumes were 10 µl, and we amplified 55 cycles with a touchdown PCR profile (lowering the annealing temperature from 65°C in the first cycle to 55°C in the 10th cycle in 1°C/cycle steps).
Optimizing genotyping assays
Overall, we achieved robust genotyping for 12 of 14 genotyping assays with our standard approach (Figure 1), relying mainly on a touchdown PCR protocol and asymmetric amplification (preferentially amplifying the PCR strand complementary to the anchor and sensor probes). For two assays (COMT and MAOA), we had to take additional measures in order to get good genotyping quality.
COMT V158M polymorphism
The standard approach gave very uneven melting peaks for the mismatch (low temperature melting) and the perfect match (high temperature melting) alleles (Figure 2). Changes in primer or HybProbe concentrations did not improve these patterns. At this stage, we were able to distinguish only between homozygous BB genotypes (in purple) in all other genotypes (AA and AB; yellow and blue samples) and thus had lost discrimination power. Finally, we decided to move the unlabeled forward primer 50 bases upstream and, by this simple measure, greatly improved the robustness of the genotyping assay. Re-genotyping gave us reliable genotypes for 268 samples (1.5% technical failures).
In this case, again, melting curves for the high temperature melting peak were polymorphic and did not allow accurate grouping of genotypes (Figure 2). A skewed melting profile did not reliably distinguish between AB genotypes (yellow traces) and BB genotypes (red traces). There, we observed much better melting profiles in 20 µl volume assays and therefore re-genotyped a technically identical assay in a doubled PCR volume. Likewise, we were able to reliably genotype all samples for MAOA (1.9% technical failure probably due to bad DNA quality).
Results and Discussion
We have genotyped 14 SNPs in a cohort of 272 smokers. Overall performance of the system was high with drop-out rates below 3%. Three SNPs (SLC6A4, HTR2A, RAPGEF) were mis-annotated in the public databases and did not show heterozygosity although the PCR performance was very robust. MAOA and COMT genotyping had to be improved by shifting the unlabeled forward primer or increasing the reaction volume from 10 µl to 20 µl.
Eleven SNPs were polymorphic in our cohort. For these 11 SNPs, genotype counts did not significantly deviate from Hardy-Weinberg equilibrium. Therefore, the accuracy of the genotyping system is high. Moreover, we validated SNPs for ANKK1 by an independent method (RFLP; data not shown) giving exactly identical genotypes. The success rate for genotyping in this study was more than 95% (Table 1), with no evidence for a technical performance failure of the LightCycler® 480 Instrument.
Our genotyping data indicate that analyses of genetic variation in the dopaminergic system are feasible using the LightCycler® 480 Instrument with HybProbes. This new high-throughput technology has enabled more reliable genotyping and thus more accurate analyses of genetic variants and smoking behavior. Future studies will report on these clinically relevant associations.
1. Walter et al. (2006) Biochemica 2:8–11
We thank IS Mäckle-Jentsch and Claudia Bauer for their excellent technical assistance.
This article was originally published in Biochemica 3/2007, pages 10-12. ©Springer Medizin Verlag 2007
- TIB Molbiol
- genetic markers
Transfection of cells is one of the main techniques used to influence gene expression. Most primary cells and human skeletal myoblasts (SkMC) in particular are very difficult to transfect, whereas for cell lines such as C2C12, many suitable transfect more
One of the most interesting aspects of real-time PCR based on detection of fluorophoric-labeled oligonucleotides, such as Hydrolysis probes, and Molecular Beacons, is the possibility of being able to detect conveniently multiple targets in the same more
Roche and SynenTec announced that Roche will transfer its Cellavista business to SynenTec, the German company which is the original inventor of the Cellavista System. This agreement was made as a result of the Roche Applied Science decision to focus its business, and guarantees future optim ... more
A team of researchers from Roche, including scientists from Roche Pharma Research and Early Development and Roche NimbleGen, reported in Genome Research that they have generated the first draft genome sequence of the cynomolgus monkey (Macaca fascicularis) and developed a novel microarray d ... more
The xCELLigence RTCA System of Roche is being used in the European Union’s DETECTIVE ("Detection of endpoints and biomarkers for repeated dose toxicity using in vitro systems”) Project, a joint study funded by the European Cosmetics Association (Colipa) and the European Commission, where Ro ... more